Fund Holdings — Camber Capital Management LP

Total Portfolio Value
$2.57M
Total Bought
$517.3K
Total Sold
$595.9K
Net Transaction
-$78.6K
Filing Period:
Securities
▲▼
SharesValue ($K)
Q2 2024
▲▼
Q3 2024
▲▼
Change
▲▼
Q2 2024
▲▼
Q3 2024
▲▼
Weight (%)
▲▼
Change
▲▼
ASCENDIS PHARMA A/S(ASND)0700,000+700,00001054.06%+105
SAREPTA THERAPEUTICS INC(SRPT)150,000775,000+625,00024973.76%+73
MEDTRONIC PLC(MDT)2,250,0002,750,000+500,0001772489.62%+70
BAXTER INTL INC5,500,0006,500,000+1,000,0001842479.59%+63
ZIMMER BIOMET HOLDINGS INC(ZBH)1,925,0002,500,000+575,00020927010.48%+61
CONCENTRA GROUP HOLDINGS PAR(CON)01,975,000+1,975,0000441.72%+44
MEDPACE HLDGS INC(MEDP)0125,000+125,0000421.62%+42
EVOLENT HEALTH INC(EVH)625,0001,400,000+775,00012401.54%+28
PTC THERAPEUTICS INC(PTCT)3,500,0003,500,00001071305.04%+23
GSK PLC(GSK)2,675,0003,000,000+325,0001031234.76%+20
VIATRIS INC(VTRS)15,000,00015,000,00001591746.76%+15
DENALI THERAPEUTICS INC(DNLI)2,000,0002,000,000046582.26%+12
QIAGEN NV(QGEN)1,500,0001,500,000062682.65%+7
MOONLAKE IMMUNOTHERAPEUTICS(MLTX)355,000441,000+86,00016220.86%+7
CVS HEALTH CORP(CVS)1,500,0001,500,000089943.66%+6
ALKERMES PLC(ALKS)0200,000+200,000060.22%+6
JAZZ PHARMACEUTICALS PLC(JAZZ)1,150,0001,150,00001231284.98%+5
INOGEN INC(INGN)2,000,0002,000,000016190.75%+3
BICYCLE THERAPEUTICS PLC915,000915,000019210.80%+2
ORASURE TECHNOLOGIES INC(OSUR)4,250,0004,250,000018180.70%0
GENMAB A/S(GMAB)50,00050,0000110.05%-0
BROOKDALE SR LIVING INC(BKD)250,000250,000023230.90%-0
THERAVANCE BIOPHARMA INC(TBPH)1,000,0001,000,0000880.31%-0
CUREVAC N V550,0000-550,00020—-2
THE BEAUTY HEALTH COMPANY(SKIN)3,500,0001,500,000-2,000,000720.08%-5
HERBALIFE LTD(HLF)3,000,0003,000,000031220.84%-10
BROOKDALE SR LIVING INC(BKD)15,500,00013,935,000-1,565,000106953.67%-11
REPLIMUNE GROUP INC(REPL)1,350,0000-1,350,000120—-12
ANAPTYSBIO INC500,0000-500,000130—-13
SELECT MED HLDGS CORP2,550,0002,125,000-425,00089742.88%-15
ZIMVIE INC3,250,0002,725,000-525,00059431.68%-16
GLOBUS MED INC(GMED)2,500,0002,150,000-350,0001711545.97%-17
MYRIAD GENETICS INC(MYGN)5,500,0003,950,000-1,550,0001351084.20%-26
ARGENX SE(ARGX)72,0000-72,000310—-31
PERRIGO CO PLC(PRGO)1,520,0000-1,520,000390—-39
WALGREENS BOOTS ALLIANCE INC7,000,0000-7,000,000850—-85
HUMANA INC(HUM)400,000200,000-200,000149632.46%-86
BIOMARIN PHARMACEUTICAL INC(BMRN)1,100,0000-1,100,000910—-91
UNIVERSAL HLTH SVCS INC(UHS)950,000125,000-825,000176291.11%-147
Page 1 of 1
Camber Capital Management LP — 13F Holdings — Q3 2024 | TickerTrail